“hemophilia” Archives

in
Entry Author Date Location
FDA Rejects BioMarin Hemophilia Gene Therapy, Asks for More Data 08/19/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy 03/16/20 Europe
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
As Sangamo Touts Data, BioMarin Preps Hemophilia Gene Therapy For FDA 07/08/19 San Francisco
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits 06/26/19 San Francisco
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D 05/23/19 San Francisco
ElevateBio Gets $150M to Grow a Crop of Gene & Cell Therapy Startups 05/13/19 Boston
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases 04/08/19 Boston
Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues 03/25/19 Boston
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again 02/14/19 National
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy 01/31/19 New York
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More 12/21/18 National
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Bio Roundup: CRISPR Babies, Blood Diseases, Big Cancer Nod & More 11/30/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Data Starts Stretch Run for UniQure’s Upgraded Hemophilia Gene Therapy 11/15/18 Boston
FDA Approves Roche Drug For All Hemophilia A Patients, But Rivals Loom 10/04/18 San Francisco
Syntimmune Turns Drug For Rare Anemia Into $400M Alexion Buyout 09/26/18 Boston
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More 08/10/18 National
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Bio Roundup: Big Bucks For Calico, Data Dumps & The IPO Wave Rolls On 06/29/18 National
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Data Could Make Roche Drug a Hemophilia Standard, But for How Long? 05/21/18 San Francisco
Bio Roundup: Spark v. ICER, A Solid Revelation, T Cell Deals & More 01/26/18 National
Page 1 of 4 next page »